Notice of Change to Award Project Period for PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
Notice NOT-NS-23-107 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2023 Category: Research Source Type: funding
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
Funding Opportunity RFA-MH-24-190 from the NIH Guide for Grants and Contracts. Reissue of RFA-MH-21-205 to comply with DMS Policy. This Notice of Funding Opportunity (NOFO), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, is one of several NOFOs aimed at supporting transformative discoveries that will lead to breakthroughs in understanding human brain function. Guided by the long-term scientific plan, BRAIN 2025: A Scientific Vision, this NOFO specifically seeks to support efforts addressing core ethical issues associated with research focused on the human brain an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 1, 2023 Category: Research Source Type: funding
Notice of Informational Webinar for RFA-NS-24-006 and RFA-NS-24-007 "Community-Engaged Health Equity Research in Neuroscience Initiative" Notices of Funding Opportunity (R01 and R34)
Notice NOT-NS-23-109 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 30, 2023 Category: Research Source Type: funding
Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-25-145 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity announcement (NOFO) supports systematic and scalable approaches to profile the biological function of genes with an excess of damaging mutations in patients with neurodevelopmental and psychiatric disorders. Current understanding of the relationship between genetic and phenotypic variation is limited and one of the main bottlenecks in translating disease-associated genes to biology lies in the lack of scalable experimental platforms that can extend the unbiased nature of gene discovery to the discovery of bi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 30, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
Notice NOT-NS-24-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 29, 2023 Category: Research Source Type: funding
Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-24-235 from the NIH Guide for Grants and Contracts. HIV associated CNS complications are a significant problem for people living with HIV despite suppressive anti-retroviral therapy. HIV enters the CNS as early as 8 days after infection and can cause several complications including cognitive, neurological and mental health related issues. Although experts have gathered much data on underlying HIV-induced CNS pathophysiology, specific targeted causality remains elusive, and no effective therapies exist to slow, stop, or reverse these adverse outcomes. This initiative is to comprehend the action...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 29, 2023 Category: Research Source Type: funding
Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-027 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) promotes collaborative research programs to support the development/enhancement of infrastructure (e.g., tools, surveys, biospecimens, data) for Alzheimer's disease (AD) and AD-related dementias (AD/ADRD) neuroscience research in low- and middle-income countries (LMICs) in Africa. Specifically, the National Institute on Aging (NIA) seeks to support Phase Innovation Awards Cooperative Agreement (UG3/UH3) projects to enable: (1) the formation of transformative collaborations between institutions/scienti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2023 Category: Research Source Type: funding
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Funding Opportunity PAR-23-274 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD). Candidate interventions evaluated through this program, which can include small molecules or biologics for example, must engage non-amyloid/non-tau mechanisms and aim to address cognitive and/or neuropsyc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2023 Category: Research Source Type: funding
Notice of Change in Eligibility to Part I for RFA-DK-23-001 "A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed)"
Notice NOT-DK-23-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 22, 2023 Category: Research Source Type: funding
NIH All About Grants Podcast: Reporting on Your Scientific Progress
Tom Cheever, Program Officer, National Institute of Neurological Disorders and Stroke, NIH
As part of proper stewardship and transparency, recipients must periodically tell NIH about their research progress outcomes and accomplishments when receiving an award (see NIH Grants Policy Statement Section 8.4.1 for policy and regulatory references). What exactly should someone report on and when though?
Dr. Tom Cheever, a program officer with the National Institute of Neurological Disorders and Stroke, explains more about progress reporting in this episode of the NIH All About Grants podcast. Join us as we discuss what the ...
Source: NIH Extramural Nexus - August 18, 2023 Category: Research Authors: NIH Staff Tags: New Resources Grants policy podcast RPPR Source Type: funding
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 18, 2023 Category: Research Source Type: funding
Notice of Change in Eligibility to Section III for RFA-DK-22-036 "A Consortium for Gut-Brain Communication in Parkinsons Disease (U01 Clinical Trial Not Allowed)"
Notice NOT-DK-23-031 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 17, 2023 Category: Research Source Type: funding
NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-23-030 from the NIH Guide for Grants and Contracts. The purpose of the Clinical Trial Methods in Clinical Neurological Disorders Course" Notice of Funding Opportunity Announcement (NOFO) is to increase the reliability and effectiveness of clinical trials and to enhance the training of investigators new to clinical trials. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 16, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Recipients to Support Resource Dissemination
Notice NOT-EB-23-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 16, 2023 Category: Research Source Type: funding
Addressing Rigor in Scientific Studies
Guest blog by Devon C. Crawford, Ph.D., Program Director, Office of Research Quality, NIH’s National Institute of Neurological Disorders and Stroke. Originally published on the NIH Science, Health, and Public Trust blog.
Devon C. Crawford, Ph.D., Program Director, Office of Research Quality
Science communication is rapidly evolving. The growing use of preprints and the sheer number of published studies make it increasingly difficult to determine which findings are worthy of attention. Not all scientific studies are created equal. Communicators need to discern which are reputable in order to know what to co...
Source: NIH Extramural Nexus - August 14, 2023 Category: Research Authors: NIH Staff Tags: blog Open Mike Grants policy rigor Source Type: funding
